Epithelial-to-Mesenchymal Transition and Oncogenic Ras Expression in Resistance to the Protein Kinase Cβ Inhibitor Enzastaurin in Colon Cancer Cells

Abstract Identifying molecular factors of sensitivity and resistance of cancer cells to enzastaurin, a drug inhibiting protein kinase C (PKC) β, remains a major challenge to improve its clinical development. Investigating the cellular effects of enzastaurin in a panel of 20 human cancer cell lines,...

Full description

Saved in:
Bibliographic Details
Published inMolecular cancer therapeutics Vol. 9; no. 5; pp. 1308 - 1317
Main Authors Serova, Maria, Astorgues-Xerri, Lucile, Bieche, Ivan, Albert, Sebastien, Vidaud, Michel, Benhadji, Karim A., Emami, Shahin, Vidaud, Dominique, Hammel, Pascal, Theou-Anton, Nathalie, Gespach, Christian, Faivre, Sandrine, Raymond, Eric
Format Journal Article
LanguageEnglish
Published 01.05.2010
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Identifying molecular factors of sensitivity and resistance of cancer cells to enzastaurin, a drug inhibiting protein kinase C (PKC) β, remains a major challenge to improve its clinical development. Investigating the cellular effects of enzastaurin in a panel of 20 human cancer cell lines, we found that most cells displaying oncogenic K-Ras mutations also display resistance to enzastaurin. Wild-type (WT) K-Ras cancer cells displaying high sensitivity to enzastaurin also expressed high mRNA levels of epithelial markers, such as E-cadherin (CDH1), and low mRNA expressions of mesenchymal markers, such as vimentin, N-cadherin (CDH2), and other genes frequently expressed in mesenchymal transition such as ZEB1, TWIST, SLUG, SNAIL, and TGFβ. WT K-Ras enzastaurin-resistant cells also expressed high levels of mesenchymal markers. Based on this observation, the effects of enzastaurin were investigated in epithelial colon COLO205-S cells that expressed WT Ras/Raf and its derived COLO205-R mesenchymal counterpart selected for resistance to most PKC modulators and displaying oncogenic K-Ras (G13D/exon 2). In COLO205-S cells, inhibition of phosphorylated PKCβ led to the inactivation of AKT and glycogen synthase kinase 3β and was associated with apoptosis without significant effect on cell cycle progression. In COLO205-R cells, enzastaurin induced mainly necrosis at high concentrations. In COLO205-R cells, a strong activation of extracellular signal-regulated kinase 1/2 possibly due to oncogenic K-Ras was predominantly associated with transcription of potent antiapoptotic genes, such as BCL2, GADD45B, and CDKN1A, as well as the multidrug resistance gene ABCB1. From this study, colon cancer cells undergoing apoptosis under enzastaurin exposure seem to frequently express a WT Ras and an epithelial phenotype. Mol Cancer Ther; 9(5); 1308–17. ©2010 AACR.
ISSN:1535-7163
1538-8514
DOI:10.1158/1535-7163.MCT-10-0167